Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

FM Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 2
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Software
  • Hardware
Summary

The company was established in Europe in Italy. The main office of represented VC is situated in the Verona.

The standard case for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are VINCI CAPITAL, Swisscom Ventures, Iris Capital. In the next rounds fund is usually obtained by Sofinnova Partners, Innogest Capital, Genextra.

The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2006. The higher amount of exits for fund were in 2011. Deals in the range of 5 - 10 millions dollars are the general things for fund.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Datamars, Erydel. Among the most successful fund investment fields, there are Hardware, Pharmaceutical. The fund has exact preference in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Switzerland.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of FM Management:
There are no funds here. If we find new data, we will add it here.
Typical Co-investors
FM Management is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after FM Management:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Autohome Beijing, China, Haidian
High Tech Private Equity Germany, Saxony-Anhalt, Zehrental
Mintel England, London, United Kingdom
Nordson Ohio, United States, Westlake
Orchid India -
Seven Seas Partners California, Menlo Park, United States
Strand Venture Partners California, Los Angeles, United States
TURNER New York, New York, United States
WolfPack Ventures California, San Diego, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Erydel

Biotechnology
Health Care
Pharmaceutical
$2M01 Dec 2008 Molise

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent FM Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 5M
Peak activity year 2008
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Erydel

Biotechnology
Health Care
Pharmaceutical
$2M01 Dec 2008 Molise
Crunchbase icon

Content report

The following text will be sent to our editors: